Dr. Pat Basu, a Board Certified Physician, is the Chief Medical Officer of Doctor on Demand. He was previously the Chief Operating Officer, Chief Medical Officer, and Director on the Board at vRad – the largest technology enabled national radiology practice. Dr. Basu also served on the State Board of Health in Illinois. Dr. Basu helped shape economic and health care agendas during his time as a White House Fellow, and has also held faculty and research appointments at Stanford University that centered on health care cost, access and quality. Throughout his career he has consulted for Fortune 500 companies, venture capital firms, and major medical centers on growth strategy, cost containment, revenue enhancement, and operational optimization. Dr. Basu holds a Medical Doctorate and Masters in Business Administration from University of Chicago. He holds a degree in Mechanical Engineering from University of Illinois.
Paul Bleicher, MD, PhD, is the CEO of Optum Labs, an open, collaborative health care research and innovation center established by Mayo Clinic and Optum. Before this, he was CMO of Humedica, where he had responsibility for medical informatics, data analytics, and product management. Prior to Humedica, he was the founder of Phase Forward, the leading provider of integrated clinical trial data management software and safety solutions. Previously, he led clinical trials at a biotechnology company and a CRO. Dr. Bleicher trained in internal medicine and dermatology, and began his career as a physician/investigator on the faculty of MGH/Harvard Medical School.
Alexis Borisy is a Partner at Third Rock Ventures, where he focuses on the formation, development and strategy of new companies. He co-founded, served as interim CEO and is currently Chairman of the Board of both Foundation Medicine and Warp Drive Bio, and co-founded and served as interim CEO of Blueprint Medicines. He is also a Board Member of Editas Medicine and Revolution Medicine.
Brad Brooks is the Co-Founder and CEO of TigerText. He is also the Co-Founder of the secret-sharing app, Whisper. Before starting TigerText, Brad served as president for six years at DIC Entertainment, a children’s-branded media company that produced, distributed and licensed content globally. With the backing of Bain Capital, Brad acquired DIC from the Walt Disney Company in 2000, where he helped grow the company from less than $10mm of revenues to over $80mm. In 2005, he took the company public on the London Stock Exchange at a $200mm valuation. Prior to DIC, he worked for investment banking corporation Donaldson, Lufkin and Jenrette. Brad received his BA from UC Berkeley and an MBA from the University of Chicago.
Todd invests in growth stage healthcare companies. Todd is currently a Director of AirStrip, Health Catalyst, MedExpress, Natera, PerfectServe, SVBio and ZirMed.
Prior to joining Sequoia Capital, Todd was the CEO of the Accountable Care Solutions business at Optum, the technology and services arm of UnitedHealth Group. Prior to that Todd was CEO of Picis, a provider of high acuity care electronic medical record software for hospitals acquired by UnitedHealth Group in 2010.
Earlier, Todd led Marquette Medical Systems to IPO and later sale to GE. Todd has a BA from Marquette University and is a graduate of the Harvard Business School PMD program.
Sean Duffy is the co-founder and CEO of Omada Health, one of Fast Company’s “50 Most Innovative Companies in the World.” Omada Health is a digital health company dedicated to inspiring and empowering people everywhere to live free of chronic disease. The company’s flagship product, Prevent, is a 16-week, CDC-recognized program that lowers participants’ risk for obesity-related chronic disease using cutting-edge technology, world-class design, and the power of social networks.
An in-demand speaker and thought leader, Sean’s accolades include a spot on The San Francisco Business Times’ 2015 list of “40 Under 40,” J.P. Morgan’s list of the “100 Most Intriguing Entrepreneurs of 2014,” and Diabetes Forecast magazine’s list of “2014 Diabetes All Stars.”
Prior to Omada, Sean worked at both Google and IDEO. A former MD/MBA candidate at Harvard, he holds a BS in neuroscience from Columbia University.
>Darren Dworkin is Senior Vice President of Enterprise Information Systems and Chief Information Officer of the Cedars-Sinai Health System in Los Angeles, California. Additionally, Mr. Dworkin is the co-founder of Stanson Health (www.stansonhealth.com) and the managing director of Summation Health Ventures (www.shv.io). Mr. Dworkin has spent over 25 years in information Technology and over 15 in healthcare.
At Cedars-Sinai he has led the implementation of a comprehensive electronic medical record to help transform care through the use of advanced technology. Day to day Mr. Dworkin leads the strategy and technology operations of both the information and clinical technology teams. The Cedars-Sinai technology team has been recognized for the past 6 years as one of Computerworld’s best places to work in IT, recognized as one of the 100 most wired hospitals in the country, and a holder of the prestigious HIMSS level 7 award.
At Stanson Health he has helped to create a software solution to deliver real-time Clinical decision support at the point of care. Stanson aims to reduce low-value and unnecessary care by leveraging real-time alerts and relevant analytics to guide and influence physician’s decisions.
At Summation Health Ventures, Mr. Dworkin leads select investments and portfolio companies aligned with Summation Health Venture’s goals of providing strategic funding to privately held companies offering innovative products, services and technologies which help health care systems significantly improve performance and outcomes.
Prior to joining Cedars-Sinai, Mr. Dworkin held the position of Chief Technology Officer at Boston University Medical Center in Boston, MA. Where he led the development and deployment of the infrastructure and application framework to bring technology to the point of care.
Mr. Dworkin has been a leader helping major information technology vendors bring solutions to the healthcare vertical enabling improvements in workflow, quality and value.
Mr. Dworkin is presently on the advisory boards of Dell, AT&T, Philips, Avia, Next Wave Health, and The Scottsdale Institute.
Mr. Dworkin is a member of HIMSS, CHIME, The Wall Street Journal CIO Network, and IEEE.
A native of Montreal, Canada, Mr. Dworkin lives in Los Angeles with his wife and two daughters.
Terry Edwards is the visionary founder, president and CEO of PerfectServe. As chief executive, Edwards has dedicated himself to helping clinicians provide the best and most efficient patient care-while delivering most satisfying customer experience in the healthcare industry.
Edwards invented and developed the version one prototype of what has today evolved into the most comprehensive and secure communications and collaboration platform in the healthcare industry.
The company currently serves nearly 100,000 clinical users—including more than 50,000 physicians—in some of the leading U.S. health systems, including Advocate Health Care, Ascension Health, MemorialCare, WellStar, Memorial Hermann, St. Joseph Health and more.
Prior to starting PerfectServe, Edwards served as vice president of sales for Voice-Tel, a pioneer in the interactive voice messaging industry. Previously, he co-founded Milepost Corporation, a leading mid-west marketing communications firm. Before launching into entrepreneurial ventures, Edwards studied music at Bowling Green University and religion at Lourdes College.
Helmy is a serial entrepreneur and pioneer in the biotech industry. After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) in 2006 to work on low-cost DNA sequencing technologies. At SGTC, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-gen sequencing. In 2007, he co-founded Avantome to commercialize a low-cost, high-performance next-gen sequencing platform to seed the democratization of next-gen sequencing. As its founding CEO, he led Avantome through two rounds of financing and through acquisition by Illumina in 2008. At Illumina, Helmy was Sr Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems.
Dr. Ferris is a practicing primary care physician and SVP for Population Health Management at Partners HealthCare in Boston and an Associate Professor at Harvard Medical School. He holds degrees from Middlebury College, Oxford University, Harvard Medical School, and the Harvard School of Public Health. He leads the Partners Healthcare Pioneer Accountable Care Organization, responsible for design and implementation of system-wide care delivery changes that will improve patient health, improve patient experience of healthcare, and reduce the healthcare cost burden. He has over 90 publications in healthcare quality measurement, risk adjustment, population management, and information technology. Dr. Ferris has served on multiple committees for the Institute of Medicine, Agency for Healthcare Research and Quality, and National Quality Forum where he chaired the Consensus Standards Approval Committee. He has served as a consultant to the Congressional Research Service, National Governor’s Association, the World Health Organization, and the Institute for Healthcare Improvement.
Bill is a Partner at Flare Capital Partners, a team of proven healthcare technology venture capital investors known for delivering unrivaled strategic industry resources, insight and a total commitment to the success of the entrepreneurs with whom we have the privilege of partnering. Current and prior investments include Valence Health, ClearDATA, Iora Health, Predilytics (Welltok), Humedica (Optum Analytics), Explorys (IBM), Connance, Rise Health (Best Doctors), Pharmetrics (IMS Health) and eBenX (ADP). Prior to cofounding Flare Capital Partners in 2013, Bill was with North Bridge Venture Partners since its inception in 1994.
Mr. Hively joined Health Essentials in 2014 to spearhead the evolution and development of its medical group, GeriNet Medical Associates (GNMA). As GNMA has long been providing compassionate care to post-acute and long-term care patients, Mr. Hively will build on that history to develop GNMA into the leading provider of accountable care for at-risk, frail elderly and chronically-ill patients.
Prior to joining Health Essentials, Mr. Hively spent five years with Heritage Provider Network (HPN), a Knox-Keene licensed medical group and IPA. Most recently, he served as Senior Vice President, Medical Group Operations, where he managed a multi-specialty medical group with over 100 employed physicians and 300 staff across 25 locations and 14 medical specialties. Prior to this role, he served as IPA Administrator for HPN’s 40,000 member IPA in the San Fernando Valley.
Earlier in his career, Mr. Hively worked with several private equity and investment firms, including General Atlantic, TA Associates, and Merrill Lynch. With each organization, he was responsible for deal origination and execution with a focus on healthcare services businesses.
Regarded as a subject matter expert in healthcare administration and finance, he currently serves as an Adjunct Professor for USC’s Masters of Health Administration program. Mr. Hively received a Bachelor of Arts in Business Economics, Magna Cum Laude, from UCLA and an MBA from Stanford University’s Graduate School of Business.
Kevin King joined iRhythm in July 2012 as President, CEO, and Director, after nearly three decades of experience in the healthcare and IT industries in leadership roles. Most recently he was the President and CEO of Affymetrix, a publicly traded technology innovator in the field of genetic analysis, where he defined and led a growth strategy into new markets for downstream validation and molecular diagnostics and oversaw several acquisitions. Kevin’s business expertise spans a diverse range of markets and technologies including: genetic analysis, medical devices, enterprise clinical information systems and healthcare services for business and clinical decision support.
Prior to Affymetrix, Kevin was President and CEO of Thomson Healthcare, a $500M information services business focused on a range of healthcare-related businesses. Through product innovation, acquisition and divestiture, he strategically repositioned the business within the growing markets for data-driven services. Previously, Kevin was a senior executive at GE Healthcare, where he led several business units including Magnetic Resonance Imaging and the $900M Global Clinical Systems Business. Kevin began his career at HP’s Medical Products Group and during his fourteen year tenure held leadership roles in Sales, Marketing, R&D, and Business Development.
Kevin earned his B.A. from the University of Massachusetts in Economics and Biology and holds an M.B.A. from New Hampshire College.
William King is the founder and Chief Executive Officer of Zephyr Health; the Insights-as-a-Service leader harnessing the power of global health data to address critical business and patient needs. He drives the company’s vision, strategy and growth with a passion for real-world business solutions and actionable enterprise data and insight solutions. Under William’s leadership, Zephyr Health has grown to serve leading pharmaceutical, biotech and medical device companies across more than 15 countries. The company has operations in North America, United Kingdom and India and stands at the forefront of the digital health economy.
Previously William has held a range of global roles in sales, marketing, training and strategy with multi-national Johnson & Johnson. William holds a Bachelor of Science in Business Administration from the University of Denver and currently serves on the American Heart Association Research Roundtable Executive Board.
Stephen Kraus is a Partner at Bessemer Venture Partners, leading up the firm’s healthcare investment practice.
Steve has been recognized by Forbes Magazine as one of the top healthcare investors in the industry. Prior to joining Bessemer, Steve worked for a growth-stage, private-equity firm and as management consultant at Bain & Company. He has also worked on several different political campaigns throughout his career.
Steve graduated summa cum laude with a B.A. from Yale University and earned his MBA from Harvard, where he was a Baker Scholar. Steve currently serves as chair of the New England Venture Capital Association (NEVCA) and the Achievement Network.
Shawn Leavitt is the SVP of Global Benefits for Comcast Cable, NBCUniversal & Comcast Spectacor —one of the world’s largest media & technology companies. In this role, Shawn and his team are responsible for delivering Retirement, Health & Welfare, and Health Services programs in support of the company’s 139,000 employees. Over his 20+-year career—which has included strategic positions at Carlson, Safeway Inc., The Coca-Cola Company, and Knight-Ridder—Shawn has developed a reputation for innovation. He has implemented creative, integrated compensation and benefit strategies; managed rewards in complex global settings; developed effective employee total rewards and wellness campaigns and pioneered the “Health Advocate” model that is now a core function of any effective care management strategy.
Harry Leider, MD, MBA has over 25 years experience as a senior physician executive in a variety of innovative healthcare organizations. Currently, he is Chief Medical Officer and Group Vice President of Walgreens – responsible for developing enterprise-wide health and wellness services that provide customer value and improve patient lives. Prior to joining Walgreens, Dr. Leider was Chief Medical Officer and Senior Vice President of Ameritox, a national specialty laboratory providing medication monitoring services to physicians treating chronic pain and serious mental illness. Previously, he served as Chief Medical Officer of XLHealth, a national Disease Management company and Medicare health plan that supported seniors with common chronic illnesses.
Earlier in his career, Dr. Leider was Senior Vice President of Interactive Forums, Inc. a national healthcare market research and strategy company; and founder and President of IFI Health Solutions – its consulting division that provided services to a broad range of healthcare technology, managed care, provider, and pharmaceutical organizations – in the areas of: qualitative market research, population health, leadership training for physician executives, and clinical quality improvement.
In addition to his extensive background in population health, healthcare consulting, and market research, Dr. Leider has broad experience in managed care. He served as the Chief Medical Officer and Senior Vice President of Health Services for HealthNet, a large hospital-owned managed care organization in Kansas and Missouri, and developed all of the care management programs for multiple new health plans. Previously, Dr. Leider managed the Boston Health Center of Harvard Community Health Plan (one of the country’s leading managed care organizations.) In this role, he was the senior executive responsible for the operation of a large, urban, multi-specialty health center that employed over 40 physicians, 200 staff, and served over 25,000 members.
Dr. Leider has received national recognition for his innovative approach to developing care management programs for populations with chronic illness, educating physicians on how to be more effective leaders, and teaching executives how to improve the quality of healthcare. He speaks frequently to national audiences and serves as a fellow, core faculty member, past board member and President of the American Association of Physician Leaderhsip (AAPL). In recognition of his major contributions to leadership in healthcare, in April of 2015, Dr. Leider was awarded the designation of Distinguished Fellow by AAPL. In addition to his faculty role at AAPL, Dr. Leider recently served as a Professional Faculty member at the Johns Hopkins Carey School of Business.
Dr. Leider served on multiple Boards of healthcare organizations. In addition to his role at AAPL, he was a founding board member of the Disease Management Association of America (DMAA), served on the Board of the Institute of Aging at the University of Pennsylvania, is currently a Board Advisor to Tytocare, and recently joined the Board of the eHealth Initiative.
Dr. Leider’s publications appeared in a variety of peer-reviewed journals and books including the American Journal of Managed Care, the journal Population Health Management, The Physician’s Guide to Managed Care by Aspen Publishers, and two books published by AAPL: the Essentials of Medical Management and Practicing Medicine in the 21st Century. He also serves on the editorial boards of the Physician Executive Journal, and Population Health Management.
Dr. Leider obtained a BA from Pennsylvania State University, earned his MD from the University of Pennsylvania School of Medicine, and while a Robert Wood Johnson Clinical Scholar, earned his MBA from the University of Washington Foster School of Business. He served for six years as an attending physician at Brigham and Women’s Hospital in Boston and as a faculty member at Harvard Medical School.
Dr. Leider lives in Evanston, IL with his wife Reena and their two daughters.
Robert Mittendorff brings to Norwest Venture Partners more than a decade of operational and medical experience. Based in Norwest’s Palo Alto office, Robert focuses on investing capital in venture and growth opportunities in the healthcare sector, including digital health and healthcare IT, technology enabled healthcare services, medical devices, diagnostics, and specialty pharma. He currently serves on the board of iCardiac, and is a board observer at Crossover Health, iRhythm, and Telcare, and was involved with the initial investments in Misfit Wearables and Health Catalyst. He has also been involved in Norwest’s follow-on investment in Basis (acquired by Intel). Robert was a previous board observer at Intersect ENT (Nasdaq: XENT).
Prior to Norwest, Robert was the Vice President of Marketing and Business Development at Hansen Medical Inc. (Nasdaq: HNSN). During his tenure, he launched multiple products, including the Magellan and Sensei X robotic systems, and was involved in leading products from concept to first commercial shipment. As a corporate officer, Robert also led the Company’s partnerships with GE, Siemens, Philips and St. Jude Medical and executed transactions totaling over $100M. He created the Scientific Advisory Board and participated in two public financings.
Prior to Hansen Medical, Robert worked in the device, pharmaceutical and biotech industries with experience at a number of companies, working in strategic, business development and marketing capacities.
Robert is also a board certified emergency physician who completed his residency training at Stanford. Robert received his M.D. from Harvard Medical School and his M.B.A. from Harvard Business School. He received his B.S. in biomedical engineering from Johns Hopkins University where he played on the soccer team. He has completed fellowships under the Howard Hughes Medical Institute (neuroscience), MIT Sloan School of Management, and Harvard Business School.
Rick is the founder and CEO of Comprehend, where he is responsible for the overall direction, vision and day-to-day operations. Comprehend is a cloud-based, software solution that enables pharmaceuticals, biotechs, and medical device makers to continuously improve quality and speed of their clinical trials. Prior to Comprehend Systems, Rick spent nearly a decade developing commercial software tools used by the FDA and top pharmaceutical companies. Rick holds a bachelor’s degree in Computer Science from Carnegie Mellon University in Pittsburgh, Pennsylvania.
Anita Pramoda is the CEO of Owned Outcomes, a health analytics company that has helped >100 hospitals succeed in various value based care initiatives and bundled payments. Anita was recently the CFO at Epic Systems, a $2 billion healthcare IT company, that provides electronic medical records for >40% of the US population. Anita led Epic through a period of significant domestic market growth, its expansion into the governmental and international markets, and its launch into mobile health IT solutions. Prior to Epic, Anita helped commercialize self-healing packaging technology at Ontech. Earlier in her career, Anita worked with companies in the technology and healthcare sectors on strategic advisory and financing assignments at UBS Investment Bank and Arthur Andersen. She serves on the board of directors at Dignity Health Foundation and Allscripts (Nasdaq: MDRX).
Anita is an engineer and holds a MBA from The Wharton School, University of Pennsylvania.
Ojas Rege is VP Strategy at MobileIron. His perspective on enterprise mobility has been covered by Bloomberg, CIO Magazine, Financial Times, and Forbes. He coined the term “Mobile First” on TechCrunch in 2007, one week after the launch of the first iPhone, to represent a new model of personal and business computing. He is co-inventor on five mobility patents, including the enterprise app store and BYOD privacy policies. Ojas has been with MobileIron for seven years as the company has grown from just an idea into the fastest growing technology company in the world (Deloitte Technology Fast 500 December 2014). Prior to MobileIron, Ojas was responsible for the mobile product teams at Yahoo! and AvantGo and started his career in 1988 as product line manager at Oracle. Ojas has a BS/MS in Computer Engineering from M.I.T. and an MBA from Stanford University. He is also Board Chair for Pact, a non-profit in Oakland, California that provides adoption services for children of color and their parents. You can follow Ojas on Twitter at @orege.
A follower and fan of medtech for nearly two decades, Tom Salemi is the former bureau chief, venture capital, at Elsevier Business Intelligence, where he oversaw coverage of venture investments in medtech.
Prior to working at Elsevier, he served as senior staff writer at Windhover Information and news editor at Dow Jones where he edited the Venture Capital Analyst: Health Care, a monthly newsletter. He also oversaw the daily life science coverage of VentureWire. Before leading those publications, Tom covered Boston’s health care and life science industries for the Boston Business Journal and worked at several newspapers in the Boston area.
A lifelong resident of the Commonwealth of Massachusetts, Tom graduated from Boston University and still resides in the Boston area with his wife and two sons.
Dr. Shreeve is an Emergency Medicine physician who has been actively involved in the design, development, and distribution of health technologies that improve the delivery of care and enhance the quality of life. He is the founder and chief executive office of Crossover Health, a next generation health care delivery and management services company. Dr. Shreeve was a co-founder of Medsphere Systems Corporation, the first open source electronic health record for the healthcare enterprise. Dr. Shreeve is also founding member of the Health 2.0 technology and reform movement, serving as an advisor to the conference and spokesperson throughout the country. He earned his undergraduate degree from Brigham Young University, graduated from University of Utah School of Medicine, and completed his Emergency Medicine residency at the University of Arizona. He lives in Southern California with his wife and four children near some of the best surf breaks on the west coast.
Tom Spann is Chief Executive Officer and co-founder of Accolade, Inc., an innovative consumer services company dedicated to improving the healthcare experience and helping individuals and families get the right care the first time.
Since its founding in 2007, Accolade has grown to 600-plus employees serving some of the nation’s largest self-insured employers together with health plans and health systems. Accolade has been recognized as one of the nation’s 25 Most Promising Companies by Forbes magazine and the fastest-growing private healthcare company by Inc. 500. Employees have consistently voted the company a top workplace in the Philadelphia region and Tom a top CEO.
Prior to founding Accolade, Tom served as Senior Managing Partner at Accenture, where he led the North America Products Group, a 10,000-employee operating unit with $2-billion-plus-revenue.
Tom holds a bachelor’s degree in economics from the Wharton School of the University of Pennsylvania.
Steve Wiggins is one of the most accomplished entrepreneurs and executives in the healthcare sector, launching health services, health insurance, specialty pharmaceutical and medical technology companies over the past 30 years. Steve joined Essex Woodlands in 2007 as Operating Partner and was appointed Managing Director in February 2008.
Prior to Essex Woodlands, Steve founded Oxford Health Plans and served for 14 years as the company’s Chairman of the Board and Chief Executive Officer. Under his leadership, Oxford grew to over $5 billion in annual revenue and ranked among the 300 largest U.S. corporations. Previously, he was the Founder, Chairman and Chief Executive Officer of HealthMarket, Inc., an insurance company that gave birth to innovative Consumer Driven Health Plans and grew to over $150 million in revenue before being acquired by UICI. He co-founded Health Partners, Inc, a physician practice management company that grew to $140 million in annual revenue before it was sold. He served as co-Founder of Intelliclaim, Inc., which provided claim auditing and productivity software and services to over twenty health insurance companies before it was sold to McKesson. He was also the founding investor in BenefitPort, LLC, a consolidation of health insurance general agencies.
Steve co-leads our healthcare services and healthcare information technology investment practice and serves on the Board of Directors for Touchstone Health, ikaSystems, Millennium Pharmacy Systems and Medseek. In addition to the portfolio company boards on which he serves today, Steve also serves as Director of Accessible Space, Inc, a non-profit organization he founded in 1978, which operates residential facilities for individuals with mobility impairments and brain injuries.
Steve holds a Bachelor of Arts degree from Macalester College and a Master of Business Administration degree from Harvard Business School. He enjoys kite boarding, golfing, biking and fishing and has a keen interest in complimentary medicine and religion.
The same technologies that revolutionized the commerce, transportation, and finance industries are bearing down on the $3 trillion healthcare industry, promising to simultaneously improve care while reducing costs. The scope of revolutionary technologies includes diagnostics and monitoring, wearable devices, telehealth, medical modeling, smart devices, data management, tracking and delivery, and much more.
But innovators won't find the solutions without completely understanding the problem.
The Digital Healthcare Innovation Summit emphasizes disruptive solutions to the Health Care conundrum. Leading stakeholders from hospitals, insurers, and critical regulatory bodies sit down with the technology industry’s top innovators, investors, and entrepreneurs to discuss how technology can unwrap the inefficiencies of the massive healthcare sector. This isn’t a showcase of gadgets. It’s the source of the conversation for healthcare solutions and opportunities, delivered through new and innovative technologies.
Join us at the 5th annual Digital Healthcare Innovation Summit to learn about emerging technologies that will impact the economics of care and improve the ways we prevent and treat illness.
776 Boylston Street, Boston, MA 02199